JPMORGAN CHASE & CO - DYNAVAX TECHNOLOGIES CORP ownership

DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of DYNAVAX TECHNOLOGIES CORP
ValueSharesWeighting
Q3 2023$3,849,269
+15.1%
260,614
+0.7%
0.00%
Q2 2023$3,344,536
+61.3%
258,865
+22.4%
0.00%
Q1 2023$2,074,000
+112556.2%
211,421
+22.2%
0.00%
Q4 2022$1,841
-99.9%
173,047
+12.5%
0.00%
Q3 2022$1,606,000
-9.9%
153,811
+8.6%
0.00%
Q2 2022$1,783,000
+98.6%
141,570
+70.8%
0.00%
Q1 2022$898,000
-41.4%
82,899
-23.9%
0.00%
Q4 2021$1,533,000
+21.5%
108,921
+65.7%
0.00%
Q3 2021$1,262,000
+94.8%
65,718
-0.1%
0.00%
Q2 2021$648,000
+4.9%
65,754
+4.6%
0.00%
Q1 2021$618,000
+191.5%
62,864
+31.4%
0.00%
Q4 2020$212,000
+21.8%
47,828
+20.8%
0.00%
Q3 2020$174,000
-34.8%
39,609
+31.7%
0.00%
Q2 2020$267,000
+175.3%
30,081
+10.0%
0.00%
Q1 2020$97,000
-37.8%
27,347
+0.1%
0.00%
Q4 2019$156,000
+50.0%
27,322
-6.0%
0.00%
Q3 2019$104,000
+35.1%
29,076
+45.6%
0.00%
Q2 2019$77,000
-96.1%
19,974
-92.6%
0.00%
Q1 2019$1,970,000
-20.4%
269,540
-0.4%
0.00%
-100.0%
Q4 2018$2,476,000
-24.6%
270,575
+2.2%
0.00%0.0%
Q3 2018$3,282,000
-17.2%
264,669
+1.8%
0.00%0.0%
Q2 2018$3,966,000
-24.5%
260,078
-1.8%
0.00%0.0%
Q1 2018$5,256,000
-15.5%
264,781
-20.4%
0.00%0.0%
Q4 2017$6,222,000
-28.1%
332,781
-18.2%
0.00%
-50.0%
Q3 2017$8,648,000
+77.4%
406,938
-19.5%
0.00%
+100.0%
Q2 2017$4,876,000
+622.4%
505,227
+344.8%
0.00%
Q1 2017$675,000
+23.6%
113,595
-17.7%
0.00%
Q4 2016$546,000
-61.5%
138,015
+1.9%
0.00%
Q3 2016$1,420,000
+18.2%
135,400
+117.0%
0.00%
Q1 2016$1,201,000
-25.8%
62,400
-6.8%
0.00%
Q4 2015$1,618,000
-15.2%
66,958
-13.9%
0.00%
-100.0%
Q3 2015$1,909,00077,8000.00%
Other shareholders
DYNAVAX TECHNOLOGIES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Chicago Capital, LLC 5,782,610$25,733,0001.15%
Avidity Partners Management LP 4,000,000$17,800,0000.58%
PFM Health Sciences, LP 2,936,990$13,070,0000.46%
Rhenman & Partners Asset Management AB 925,534$4,119,0000.34%
EDMOND DE ROTHSCHILD HOLDING S.A. 1,470,000$6,542,0000.22%
JACKSON SQUARE CAPITAL, LLC 122,555$545,0000.21%
Rock Springs Capital Management LP 1,649,420$7,340,0000.16%
FEDERATED HERMES, INC. 11,946,800$53,163,0000.11%
Virtus ETF Advisers LLC 57,062$254,0000.10%
GABLES CAPITAL MANAGEMENT INC. 31,225$139,0000.08%
View complete list of DYNAVAX TECHNOLOGIES CORP shareholders